A Phase II Study of MRI-based Intraprostatic SIB (simultaneous integrated boost) Intensification with De-escalated Adaptive-risk SBRT for Patients with Low to Intermediate Risk Prostate Cancer

16999STUDY00009733-MIDAS-IITOpenA Phase II Study of MRI-based Intraprostatic SIB (simultaneous integrated boost) Intensification with De-escalated Adaptive-risk SBRT for Patients with Low to Intermediate Risk Prostate CancerSTUDY00009733NCT07644598InstitutionalAdultTreatmentIILocalProstateLischalk, JonathanLombardi Comprehensive Cancer Center : Madina Kamilova GalliherPROTOCOL Eligibility_MIDAS v7.6.26.docxGenito-urinaryOncology GroupLombardi Comprehensive Cancer Center (LCCC)17888Madina Kamilova GalliherMadina Kamilova Gallihermk2607@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>